Chung J-J, Park H J, Yu J S, Hong Y J, Kim J H, Kim M-J, Lee S I
Department of Radiology and Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul, Korea.
Acta Radiol. 2008 Jun;49(5):498-505. doi: 10.1080/02841850802010741.
Esophageal transit scintigraphy and barium esophagography have been used for evaluation of therapeutic results in patients with achalasia. It remains to be determined which method is most useful, and whether both studies are necessary before and after treatment for achalasia.
To evaluate the usefulness of both esophagography and esophageal transit scintigraphy (ETS) to determine the efficacy of endoscopic pneumatic dilatation (EPD) in patients with achalasia.
Seventeen patients (6 M, 11 F) with achalasia underwent both esophagography and ETS before and after EPD. Esophagographic findings were reviewed to determine the length and caliber of stenosis in the esophagogastric channel. Dynamic images of ETS were evaluated on time-activity curves. Changes in the clinical symptom score were evaluated. Statistical analyses of esophagography and ETS before and after EPD were performed.
After EPD, the mean symptom score improved (P<0.05). The mean residue of radioisotope in ETS also improved after EPD, with a statistically significant correlation (P<0.05). There was a statistically significant correlation between the improved symptom scores and the change in ETS after EPD (P<0.05). There was no statistical correlation between clinical symptom scores and esophageal caliber, regardless of EPD (P>0.05). With an 8-mm diameter of the esophagogastric channel as a benchmark for successful treatment, there was no statistical correlation between esophagography and ETS at 15 s after EPD (P>0.05).
Esophagography was useful for the evaluation of morphology and caliber of the esophagogastric channel, while ETS was useful for the functional evaluation of esophageal emptying. Both studies may therefore be considered necessary to evaluate the efficacy of EPD in patients with achalasia.
食管通过闪烁扫描术和食管钡餐造影已用于评估贲门失弛缓症患者的治疗效果。哪种方法最有用,以及在贲门失弛缓症治疗前后这两项检查是否都有必要,仍有待确定。
评估食管造影和食管通过闪烁扫描术(ETS)在确定贲门失弛缓症患者内镜下气囊扩张术(EPD)疗效方面的作用。
17例贲门失弛缓症患者(6例男性,11例女性)在EPD前后均接受了食管造影和ETS检查。回顾食管造影结果以确定食管胃通道狭窄的长度和管径。通过时间 - 活性曲线评估ETS的动态图像。评估临床症状评分的变化。对EPD前后的食管造影和ETS进行统计学分析。
EPD后,平均症状评分改善(P<0.05)。EPD后ETS中放射性同位素的平均残留量也有所改善,具有统计学显著相关性(P<0.05)。EPD后症状评分的改善与ETS的变化之间存在统计学显著相关性(P<0.05)。无论是否进行EPD,临床症状评分与食管管径之间均无统计学相关性(P>0.05)。以食管胃通道直径8mm作为成功治疗的基准,EPD后15秒时食管造影和ETS之间无统计学相关性(P>0.05)。
食管造影有助于评估食管胃通道的形态和管径,而ETS有助于评估食管排空的功能。因此,这两项检查对于评估贲门失弛缓症患者EPD的疗效可能都是必要的。